Monica Otto

Government, Health and Not for Profit

Biografia

Pubblicazioni recenti

JOMMI C., ARMENI P., BERTOLANI A., COSTA F., OTTO M. The future of Funds for Innovative Medicines: results from a Delphi Study Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, 2021, vol.8, pp.22-28
JOMMI C., ARMENI P., COSTA F., BERTOLANI A., OTTO M. Implementation of Value-based Pricing for Medicines Clinical Therapeutics, 2020, vol.42, no. 1, pp.15-24
OTTO M., ARMENI P., JOMMI C. Variations in non-prescription drug consumption and expenditure: Determinants and policy implications Health Policy, 2018, vol.122, no. 6, pp.614-620
OTTO M., Pillarella C., JOMMI C. The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy Frontiers in Pharmacology, 2018, vol.9, no. 1069
ARMENI P., BERTOLANI A., COSTA F., OTTO M., JOMMI C. L’acquisto di farmaci in Italia: l’effetto di approcci selettivi in Rapporto OASI 2018 CERGAS (a cura di), Egea, chap. 17, pp.611-648, 2018
ARMENI P., BERTOLANI A., JOMMI C., OTTO M. Le previsioni sulla spesa e i consumi di farmaci senza obbligo di prescrizione: il triennio 2017-2019 in Numeri e indici dell’automedicazione Centro Studi Assosalute (a cura di), Federchimica Assosalute, chap. 4, pp.159-174, 2017

Articoli correlati

Hospital Management during pandemic crisis: Lessons Learn...
Autori
Tempo richiesto 1 ora